These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 443593
1. Cardiac function and hemodynamic parameters after pentaerythritol tetranitrate: assessment by a noninvasive radionuclide technique. Winsor D, Winsor T. Angiology; 1979 Apr; 30(4):266-75. PubMed ID: 443593 [Abstract] [Full Text] [Related]
2. Cardiac function and hemodynamic parameters after pentaerythritol tetranitrate. Assessment by new noninvasive radionuclide technique. Winsor T. Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2465-9. PubMed ID: 7422536 [Abstract] [Full Text] [Related]
3. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure. Shah PK, Shellock FG, Berman DS, Rubin SA, Singh BN, Swan HJ. Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2447-50. PubMed ID: 7422534 [Abstract] [Full Text] [Related]
4. [The hemodynamic profile of pentaerythrityl tetranitrate]. Engelmann L, Gottschild D. Z Gesamte Inn Med; 1981 Apr 01; 36(7):244-6. PubMed ID: 7281826 [Abstract] [Full Text] [Related]
5. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure. Shellock FG, Shah PK, Berman DS, Rubin SA, Singh BN, Swan HJ. Clin Pharmacol Ther; 1980 Oct 01; 28(4):436-40. PubMed ID: 7408403 [Abstract] [Full Text] [Related]
6. [Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance]. Dück KD, Richard F. Z Gesamte Inn Med; 1990 Dec 15; 45(24):736-41. PubMed ID: 2129317 [Abstract] [Full Text] [Related]
7. [Pulmonary artery pressure measurement for assessment of bioavailability of isosorbide dinitrate and pentaerythritol tetranitrate (author's transl)]. Gaul G, Aldor E. Wien Med Wochenschr; 1980 Jan 15; 130(1):21-5. PubMed ID: 6994369 [Abstract] [Full Text] [Related]
14. The effect of pentaerythritol tetranitrate pretreatment on experimental coronary occlusion. Meester WD, Van Harn GL. Am Heart J; 1974 Sep 15; 88(3):330-7. PubMed ID: 4854772 [No Abstract] [Full Text] [Related]
15. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity. Amsterdam EA, Lee G, Awan NA, Low R, Mason DT. Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2443-6. PubMed ID: 7422533 [Abstract] [Full Text] [Related]
16. [Drug treatment of chronic coronary disease]. Halawa B. Wiad Lek; 1980 Jan 15; 33(2):107-11. PubMed ID: 6768197 [No Abstract] [Full Text] [Related]
17. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate]. Warembourg H, Théry C. Lille Med; 1966 Jan 15; 11(6):742-5. PubMed ID: 5942195 [No Abstract] [Full Text] [Related]
18. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure. Fraccarollo D, Galuppo P, Neuser J, Bauersachs J, Widder JD. Hypertension; 2015 Nov 15; 66(5):978-87. PubMed ID: 26351025 [Abstract] [Full Text] [Related]